Some clients may notice mild swelling, redness, or bruising at injection sites, but these effects usually settle within a few days
Five milligrams of each therefore corresponds to approximately 3.5 mol of BPC-157 against approximately 1.0 mol of TB-500, a molar ratio near 3.5 to 1 rather than 1 to 1, and any calculation expressed in molar terms has to account for that
Protocols combining BPC-157, TB-500, and GHK-Cu address different aspects of healing simultaneously: local tissue repair, reduced scarring, and collagen regeneration
KLOW is excluded during active cancer treatment
Patients were to be randomized to 1200 mg, 450 mg, or placebo, administered intravenously daily for 3 days followed by weekly for 4 weeks